Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Nechushtan
182P: Intracranial Response to Nivolumab in NSCLC Patients With Untreated or Progressing CNS Metastases
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-02 Osimertinib for EGFR-Positive Advanced NSCLC With Brain Metastases: Preliminary Analysis of an Open-Label, Two-Arm, Phase 2 Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Osimertinib Treats CNS Metastases in NSCLC
Cancer Discovery
Oncology
P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Elemene Treatment for NSCLC With Multiple CNS Metastases: A Case Report and Literature Review
OncoTargets and Therapy
Oncology
Pharmacology
Cannabis Impacts Tumor Response Rate to Nivolumab in Patients With Advanced Malignancies
Oncologist
Cancer Research
Medicine
Oncology
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy
JAMA Oncology
Cancer Research
Oncology
P2.04-10 Early Monitoring of Blood Biomarkers to Predict Nivolumab Efficacy in NSCLC Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Development of CNS Metastases and Survival in Patients With Inflammatory Breast Cancer
Cancer
Cancer Research
Oncology
MA08.11 Early Safety Data of a Phase I/Ii Combining Nivolumab and Stereotactic Brain Radiosurgery for Treatment of Brain Metastases in Patients With NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P023 Factors Associated With Administration of Subsequent Cytotoxic Chemotherapy After Nivolumab in Patients With Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
